Skip to search.
 TSX Up 0.37% TSX Ventures  0.00%
Streaming
Ticker Tape: On

Nektar Therapeutics (NKTR)

-NasdaqGS
10.97 Down 0.08(0.68%) Apr 17, 4:00PM EDT
Add to Portfolio
Prev Close:11.05
Open:10.99
Bid:10.10 x 500
Ask:11.90 x 2000
1y Target Est:15.14
Beta:1.53
Earnings Date:May 5 - May 9 (Est.)
Day's Range:10.69 - 11.24
52wk Range:8.72 - 15.34
Volume:1,648,233
Avg Vol (3m):1,428,340
Market Cap:1.39B
P/E (ttm):N/A
EPS (ttm):-1.40
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NKTRDown 0.68%1.39B
BMYUp 0.71%81.62B
ENZNDown 1.29%43.00M
GSKDown 0.59%125.79B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.39
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.64
Quarterly EPS Est (Mar-14) :0.09
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-0.86

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nektar Therapeutics, a clinical-stage biopharmaceutical company, develops drug candidates that utilize its PEGylation and polymer conjugate technology platforms in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback